Sept 29 (Reuters) – Metsera Inc: * METSERA REPORTS POSITIVE PHASE 2B RESULTS FOR FIRST- AND BEST-IN-CLASS ULTRA-LONG ACTING GLP-1 RA CANDIDATE MET-097I, ENABLING RAPID TRANSITION INTO PHASE 3 * METSERA INC – MET-097I SHOWS 14.1% WEIGHT LOSS AFTER 28 WEEKS * METSERA INC – MET-097I SHOWS CLASS-LEADING TOLERABILITY IN TRIALS * METSERA INC – DATA SUPPORTS PHASE 3 INITIATION IN LATE 2025 Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Oct 21 (Reuters) - Epic Games said its shooter title "Fortnite" will return to Apple's…
Oct 22 (OPTA) - Scoreboard at close of play on the fourth day of match…
DRONE HITS ENERGY INFRASTRUCTURE IN KREMENCHUK AREA IN UKRAINE'S POLTAVA REGION, LOCAL OFFICIAL SAYS (The…
SYDNEY, Oct 22 (Reuters) - A class-action lawsuit has been filed in an Australian court…
SPOT GOLD FALLS NEARLY 1% TO $4,104.18/OZ (The article has been published through a syndicated…
Oct 21 (Reuters) - A Chinese state-aligned hacking group used an AI-driven penetration testing tool…